Posted in education
I often hear a number of our non US members, of which there are many, have a hard time understanding why Americans are the way we are.
This documentary is non partisan, highly accurate, and in depth. Worth your time if you want to understand Americans, our attitudes, cultures, and thinking.
Why did the United States become a global superpower? America The Story of Us is an epic 12-hour television event that explores the country’s remarkable journey.
Elon Musk is often referred to as the real-life Tony Stark, aka Iron Man, and in the new quest to engineer an electric vehicle battery that lasts up to 1 million miles, iron may play the role of hero.
The U.S. Navy’s first CMV-22B Osprey for operational use arrived at Naval Air Station North Island, June 22. The tilt-rotor aircraft configured for Carrier Onboard Delivery (COD) missions is replacing the C-2A Greyhound.
=====================
The aircraft is assigned to the “Titans” of Fleet Logistics
Multi-Mission Squadron VRM 30, the Navy’s first CMV-22B squadron. VRM-30
was established in 2018 to begin the U…S Navy’s transition from the
C-2A Greyhound to the CMV-22B Osprey.
The CMV-22B is designed to carry up to 6,000 pounds of cargo and/or
personnel and operate up to a range of 1,150 nautical miles. One of the
reasons the Navy selected the V-22 airframe to serve in the COD role is
because of its ability to carry the F135 engine power module used by the
F-35C Lightning II Joint Strike Fighter.
=====================
For new videos every week, subscribe here! https://www.youtube.com/c/NavalNews?sub_confirmation=1
Follow us on Twitter: https://twitter.com/navalnewscom
Follow us on LinkedIn: https://www.linkedin.com/company/navalnews
Like us on Facebook: http://fb.me/navalnewscom
Check out our daily naval defense news coverage at: https://www.navalnews.com/
NAVAL NEWS is fully focused on naval topics. We cover the latest naval defense shows & events. We also report on naval technology from all over the world. Navalnews.com is updated daily with in-depth features, industry, and naval forces news round-ups, event coverage, video reports and more. Our top of the line site is responsive across all mobile and desktop devices.
Dr Alexis Kirke of the University of Plymouth has demonstrated the use of teleportation in music jamming.
The wet season is living up to its name across India and Bangladesh as one community received over 6 feet of rain in a five-day stretch and hundreds of thousands have become stranded. And more rain is in the forecast.
On June 29 a satellite passing over Russia’s arctic north captured an intriguing image. It looks like a rocket plume racing across the sky, but it is in fact Russia’s latest submarine.
EVPassport is an upcoming app that promises $39/mo unlimited charging on major EV charge networks. The included networks are Electrify America, EVgo, Chargepoint, Hubject and Greenlots, along with some smaller regional networks on the US West Coast. The app plans to launch in “a few weeks” but is taking wait list signups now.
The app will start with support for iPhone and DC fast charging in the US at first, with initial support for 2,500 DC chargers. It will expand to Android later this year, along with European support (including IONITY). If all goes well, it plans to add Level 2 AC charging support next year.
Two documents dating back to 2015 shed further light on the role the federal government played in discovering remdesivir and its use in treating coronaviruses — work that has taken on new meaning as the Gilead Sciences (GILD) drug has gained global attention and an emergency use authorization from federal regulators to treat patients with Covid-19.
Reporting from the frontiers of health and medicine.
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.
Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.
“We’re in uncharted territory with pricing a new medicine, a novel medicine, in a pandemic,” Gilead’s chief executive, Dan O’Day, told The Associated Press.
